triazolam has been researched along with Nephritis, Interstitial in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Nephritis, Interstitial: Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, H | 1 |
| Haramoto, T | 1 |
| Sasaki, T | 1 |
| Hironaka, K | 1 |
| Shikata, K | 1 |
| Takahashi, K | 1 |
| Ota, Z | 1 |
1 other study available for triazolam and Nephritis, Interstitial
| Article | Year |
|---|---|
Massive eosinophilic infiltration in a patient with the nephrotic syndrome and drug-induced interstitial nephritis.
Topics: Eosinophilia; Eosinophils; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Glomerulus; M | 1995 |